Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

2(33%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

33%

Ph phase_1

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

4(66.7%)

N/ANon-phased studies

2(33.3%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(3)

Detailed Status

Completed3

Recruiting1

Active, not recruiting1

Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 14 (66.7%)

N/A2 (33.3%)

Trials by Status

recruiting117%

active_not_recruiting117%

completed350%

enrolling_by_invitation117%

Recent Activity

2 active trials

Showing 5 of 6

enrolling_by_invitationphase_1

Clinical Trials (6)

Showing 6 of 6 trials

NCT07674862Phase 1

Safety, Tolerability and Pharmacokinetics of ETD-001 Gel

Enrolling By Invitation

NCT06881069Not Applicable

Reach Through Equitable Implementation in Utah

Recruiting

NCT01586403Phase 1

Transfer of Genetically Engineered Lymphocytes in Melanoma Patients

Active Not Recruiting

NCT02676674Phase 1

Vitamin D Levels Following Topical Application of Vitamin D Ointment

Completed

NCT02088203Phase 1

Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)

Completed

NCT02486978Not Applicable

Effects of Polyphenols Found in Pomegranate and Olives Food Supplements on Postprandial Blood Glucose in Vivo.

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6